Contrast Enhanced Ultrasound Market Size & Growth Forecast 2027–2036, By Segments (Product, Type, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Contrast Enhanced Ultrasound Market size was estimated at USD 2.4 billion in 2026 and is projected to grow at a 5.51% CAGR from 2027 to 2036, exceeding USD 4.1 billion by 2036. The industry revenue for 2027 is assessed at USD 2.51 billion.
Get more details on this report
Request Free Sample ReportContrast Enhanced Ultrasound Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 36.68% market share in 2026, supported by advanced diagnostic infrastructure, broad availability of ultrasound systems, and established use of contrast-enhanced imaging in clinical practice.
- Asia Pacific is projected to expand at a 6.55% CAGR as healthcare capacity grows, diagnostic imaging access improves, and providers increasingly adopt efficient, cost-effective ultrasound technologies.
Segment Momentum
- Equipment accounted for 68.83% of the market in 2026 because providers prioritize installed ultrasound platforms that support routine imaging, workflow integration, and contrast-enhanced procedures over long replacement cycles.
- Contrast agents are growing fastest because demand rises with every contrast-enhanced procedure, creating recurring utilization that expands more rapidly than capital equipment purchasing cycles.
Market Expansion Drivers
- Rising cardiovascular and liver disease burden increasing diagnostic ultrasound demand.
- Adoption of radiation-free, cost-effective imaging alternatives to CT and MRI.
- Advancements in microbubble contrast agents improving imaging sensitivity and accuracy.
Leading Market Participants
- Leading players in the contrast enhanced ultrasound market include GE HealthCare (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Bracco Imaging S.p.A. (Italy), Lantheus Holdings, Inc. (United States), Canon Medical Systems Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Samsung Medison Co., Ltd. (South Korea), Esaote S.p.A. (Italy), Guerbet Group (France).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.4 billion
- 2027 Estimated Market Size: USD 2.51 billion.
- Projected Market Size: USD 4.1 billion by 2036
- Growth Forecast: 5.51% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Equipment (Product) | Non-targeted (Type) | Hospitals (End Use)
- Emerging Opportunity Segment: Contrast Agents (Product) | Targeted (Type) | Clinics (End Use)
Market Growth Drivers and Industry Trends
Rising cardiovascular and liver disease burden increasing diagnostic ultrasound demand
A growing burden of cardiovascular and liver diseases will boost the contrast enhanced ultrasound market as healthcare providers seek more effective approaches for evaluating vascular structures, organ perfusion, and abnormal lesions. Contrast-enhanced examinations can provide additional information beyond conventional ultrasound by improving visualization of blood flow and tissue enhancement patterns. This capability is particularly relevant in conditions where lesion characterization or assessment of vascular behavior is important for diagnosis and follow-up. As the need for accessible diagnostic imaging increases across cardiovascular and hepatology care, contrast-enhanced techniques can become more valuable within routine and specialized ultrasound workflows.
Adoption of radiation-free, cost-effective imaging alternatives to CT and MRI
The availability of radiation-free imaging is supporting the contrast enhanced ultrasound market as healthcare providers consider alternatives that can deliver clinically useful diagnostic information without exposing patients to ionizing radiation. Ultrasound can also offer operational advantages through comparatively accessible equipment, flexible examination settings, and real-time imaging capabilities. Contrast enhancement further extends the modality's usefulness by improving visualization of perfusion and lesion characteristics that may not be sufficiently apparent with conventional ultrasound. These attributes make the technology particularly relevant for patients requiring repeated examinations and for healthcare settings seeking practical imaging options alongside established CT and MRI procedures.
Advancements in microbubble contrast agents improving imaging sensitivity and accuracy
Continuous development of microbubble contrast agents is strengthening the contrast enhanced ultrasound market by enabling clearer visualization of blood flow and improving the characterization of tissues and lesions. Advances in microbubble composition, stability, acoustic response, and targeting capabilities can enhance contrast behavior during ultrasound examinations, allowing clinicians to obtain more detailed information from dynamic imaging sequences. Improved agent performance can support applications involving liver lesion assessment, vascular evaluation, and treatment monitoring while increasing confidence in image interpretation. As contrast agents become more sophisticated and their clinical applications broaden, their integration into ultrasound-based diagnostic workflows is becoming increasingly valuable.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cardiovascular and liver disease burden increasing diagnostic ultrasound demand | 2.00% | High | North America, Europe | High | Near Term |
| Adoption of radiation-free, cost-effective imaging alternatives to CT and MRI | 1.60% | Moderate | North America, Asia Pacific | High | Mid Term |
| Advancements in microbubble contrast agents improving imaging sensitivity and accuracy | 1.30% | High | North America, Europe | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held a 36.68% share of the contrast enhanced ultrasound market in 2026, supported by established diagnostic infrastructure, widespread adoption of advanced imaging technologies, and growing clinical interest in radiation-free imaging approaches. Contrast enhanced ultrasound provides enhanced visualization of blood flow and tissue characteristics, supporting applications in areas such as liver, cardiovascular, and abdominal imaging. Continued development of specialized imaging capabilities, greater emphasis on minimally invasive diagnostics, and increasing clinical awareness of ultrasound-based techniques are contributing to regional demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to register the fastest growth as healthcare systems modernize diagnostic services and expand access to advanced imaging technologies. Increasing healthcare investment, rising demand for early and accurate disease detection, and broader adoption of ultrasound across hospitals are creating a favorable environment for contrast enhanced applications. The technique’s potential to support real-time imaging without ionizing radiation is also encouraging interest among healthcare providers seeking accessible and efficient diagnostic solutions.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Contrast protocol standardizationGermany contrast enhanced ultrasound market is defined by protocol-driven adoption within radiology departments. In Germany, clinicians emphasize standardized CEUS protocols for liver lesion characterization, with strong hospital-based training and increasing use as a safer alternative to CT contrast imaging in patients with renal risk profiles.
France 🇫🇷
Refined vascular imaging adoptionFrance contrast enhanced ultrasound market is shaped by structured clinical adoption within public hospitals and specialist imaging centers. In France, CEUS is increasingly used for hepatic and vascular diagnostics, with emphasis on safety-focused imaging alternatives and gradual expansion into outpatient diagnostic pathways.
Italy 🇮🇹
Regional ultrasound utilizationItaly contrast enhanced ultrasound market relies on hospital-based diagnostic networks with strong focus on liver disease management. In Italy, adoption is concentrated in gastroenterology and radiology departments, where CEUS supports cost-effective imaging strategies amid regional disparities in access to advanced cross-sectional imaging.
Japan 🇯🇵
Efficiency-driven diagnosticsJapan contrast enhanced ultrasound market focuses on efficiency and minimally invasive diagnostics in aging care settings. In Japan, hospitals increasingly adopt CEUS for liver and vascular imaging to reduce patient burden, supported by strong ultrasound equipment penetration and workflow integration in routine diagnostic pathways.
South Korea 🇰🇷
Smart hospital ultrasound systemsSouth Korea contrast enhanced ultrasound market is supported by advanced hospital digital infrastructure and rapid imaging workflow adoption. In South Korea, tertiary hospitals integrate CEUS into comprehensive diagnostic packages, particularly for oncology and liver disease screening, leveraging skilled sonographers and high device utilization rates.
United States 🇺🇸
Point-of-care ultrasound expansionThe contrast enhanced ultrasound market in the United States is driven by growing adoption of point-of-care diagnostics and liver imaging applications. In the United States, clinicians increasingly integrate CEUS into emergency and oncology workflows to reduce dependence on CT contrast agents, supported by expanding training in advanced ultrasound interpretation across hospital systems.
Segment Leadership and Growth Trends
Contrast Enhanced Ultrasound Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Equipment (Largest Segment) vs Contrast Agents (Fastest-Growing Segment)
Equipment dominated the contrast enhanced ultrasound market in 2026, accounting for 68.83% share, supported by its essential role in generating, processing, and displaying ultrasound images during contrast-enhanced examinations. Modern ultrasound systems provide clinicians with real-time visualization and increasingly sophisticated imaging capabilities, making them central to diagnostic workflows across a range of applications. Continued demand for non-invasive imaging and improvements in ultrasound functionality reinforce the importance of equipment within this market.
Contrast agents are gaining momentum as clinicians increasingly seek improved visualization of blood flow, vascular structures, and tissue perfusion. Their ability to enhance diagnostic information beyond conventional ultrasound can support more confident evaluation of complex clinical conditions while maintaining the advantages of an ultrasound-based examination. Growing interest in targeted diagnostic assessment and minimally invasive imaging approaches is creating additional opportunities for contrast agent adoption.
Type Segment Analysis: Non-targeted (Largest Segment) vs Targeted (Fastest-Growing Segment)
The non-targeted segment held the largest position in the contrast enhanced ultrasound market in 2026, reflecting its broad applicability across diagnostic examinations where generalized enhancement of vascular and tissue structures is required. Non-targeted contrast agents can be incorporated into established imaging workflows without requiring highly specific molecular targeting, supporting their use across diverse clinical indications. Their established clinical utility and compatibility with routine contrast-enhanced examinations contribute to continued demand.
Targeted contrast agents are gaining interest as molecular imaging approaches increasingly focus on identifying specific biological processes and disease-related markers. By directing contrast enhancement toward particular tissues or molecular targets, these agents can potentially provide more precise diagnostic information than generalized enhancement approaches. Increasing emphasis on personalized diagnosis and advanced imaging research is supporting greater attention to targeted ultrasound technologies.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Equipment, Contrast Agents | Equipment | Contrast Agents |
| Type | Non-targeted, Targeted | Non-targeted | Targeted |
| End Use | Hospitals, Clinics, Ambulatory Diagnostic Centers | Hospitals | Clinics |
Competitive Landscape and Market Positioning
Key companies in the contrast enhanced ultrasound market:
1. GE HealthCare (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Bracco Imaging S.p.A. (Italy)
5. Lantheus Holdings Inc. (United States)
6. Canon Medical Systems Corporation (Japan)
7. Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
8. Samsung Medison Co. Ltd. (South Korea)
9. Esaote S.p.A. (Italy)
10. Guerbet Group (France)
In the contrast enhanced ultrasound market, improved imaging techniques are enabling more detailed visualization of vascular and tissue structures. Research initiatives are enhancing contrast agent performance and imaging clarity. Continuous product improvements are expanding clinical applicability across diagnostic procedures.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Bracco Imaging S.p.A. (Italy) | |||||||
| Lantheus Holdings Inc. (United States) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China) | |||||||
| Samsung Medison Co. Ltd. (South Korea) | |||||||
| Esaote S.p.A. (Italy) | |||||||
| Guerbet Group (France). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Fujifilm Healthcare Americas Corp. | Nov-25 | Fujifilm launched the EB-710US Ultrasound Bronchoscope, a balloon-less EBUS solution. This development improves clinical workflow efficiency and reduces infection risks associated with traditional disposable balloons, while simultaneously enhancing ultrasound visualization and tissue contact for more accurate diagnostic performance. |
| GE HealthCare | Oct-25 | GE HealthCare introduced advanced contrast-enhanced ultrasound capabilities to its Venue point-of-care systems. By integrating AI-enabled workflow tools specifically for abdominal injury assessment, the company is facilitating faster, more efficient bedside procedures and improving the diagnostic utility of portable ultrasound imaging in critical care environments. |
| Philips | Oct-25 | Philips deployed Elevate software updates across its EPIQ Elite and Affiniti ultrasound platforms. The update integrates advanced AI-powered automation and image optimization features, which are designed to streamline diagnostic workflows and significantly improve image quality, thereby enhancing clinical decision-making and operational efficiency for sonographers. |
| Mindray | Oct-25 | Mindray launched the Resona A20 premium ultrasound system in Europe, expanding its high-end imaging portfolio. This new platform is engineered to deliver superior diagnostic performance, supporting a broad spectrum of complex clinical applications and strengthening the company's competitive position within the premium ultrasound equipment segment. |
| GE HealthCare | Sep-23 | GE HealthCare received a $44 million grant from the Bill & Melinda Gates Foundation to develop AI-assisted ultrasound technology. Led by its subsidiary, Caption Health, the initiative focuses on creating automated tools for maternal, fetal, and respiratory health that function across various devices, including low-cost handheld probes, to expand global access to high-quality diagnostics. |
| Bracco Imaging | Mar-23 | Bracco Imaging announced a strategic expansion of its ultrasound and MRI contrast portfolio, aiming to capture growth in underserved clinical segments. The company is actively partnering with major scanner manufacturers to promote the clinical adoption of ultrasound contrast agents, particularly within the strategic growth markets of China, Japan, and South Korea. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Contrast Enhanced Ultrasound Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Application | Abdominal Imaging, Cardiovascular Imaging, Breast Imaging, Musculoskeletal Imaging, Urological Imaging |
| Patient Group | Adult Patients, Pediatric Patients, Geriatric Patients |
| Reimbursement & Payer Type | Public/Government Reimbursement, Private Insurance Reimbursement, Self-Pay, Hospital-Funded Procedures |
Contrast Enhanced Ultrasound Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Application Expansion Assessment |
|
| CEUS Adoption Barrier Analysis |
|
| Point-of-Care Ultrasound Growth Strategy |
|
Need a different cut of the data?
Request Custom ResearchHow much is the contrast enhanced ultrasound market worth?
What is the expected industry size of contrast enhanced ultrasound by 2036?
How is the growing burden of cardiovascular and liver diseases influencing adoption of contrast-enhanced ultrasound?
How are cost and radiation concerns along with microbubble advancements affecting contrast-enhanced ultrasound utilization?
Why does equipment dominate the contrast enhanced ultrasound market?
Why are contrast agents the fastest-growing product segment in the contrast enhanced ultrasound market?
Why does North America dominate the contrast enhanced ultrasound market?
What is fueling contrast enhanced ultrasound market growth in Asia Pacific?
What are the key competitors in the contrast enhanced ultrasound landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization